Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia
<b>Background and Clinical Significance</b><b>:</b> Tyrosine kinase inhibitors (TKIs) have transformed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) into a largely manageable chronic disease. However, off-target toxicities are increasingly recognized; rarer complications such a...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2025-12-01
|
| Colección: | Diagnostics |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2075-4418/15/24/3112 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|